Please find below the latest White Papers provided by agencies and companies within the healthcare and pharmaceutical industry. These are provided by external comoanies and are not approved of, checked or edited by PMLiVE or PMGroup Worldwide Ltd.
April 11, 2022 | White Papers and Resources |
In early 2021, due to COVID-19-related safety concerns and travel and social distancing restrictions, our client needed help to “virtualize” their nationwide, multi-day, multi-business unit …
Brought to you by Impetus Digital
April 8, 2022 | White Papers and Resources |
Dice’s take on the importance of the rare diseases framework
Brought to you by Dice Medical Communications
April 5, 2022 | White Papers and Resources |
‘A third of older people in our society die with dementia. A third.’ Will the government invest more to help find a cure? (Article written …
Brought to you by Dice Medical Communications
April 4, 2022 | White Papers and Resources |
It’s hard to imagine a time when some people in the life science industry had never attended a web meeting. Yet, that’s the reality we …
Brought to you by Impetus Digital
April 4, 2022 | White Papers and Resources |
Find out how a study design which better reflects real-world choices can produce a more realistic model for the future market.
Brought to you by Inizio
April 1, 2022 | White Papers and Resources |
We’ve reached a turning point in the way we view and provide healthcare to women. In the midst of discontent with the way that women …
Brought to you by IGNIFI
March 29, 2022 | White Papers and Resources |
A key requirement for clinical trials is to understand the effect of potential treatments on the patient populations that will benefit most. Despite this, many …
Brought to you by Innovative Trials
March 29, 2022 | White Papers and Resources |
Just how important is hard hitting copy?
Brought to you by Dice Medical Communications
March 28, 2022 | White Papers and Resources |
Pharmaceutical companies know doctors want high-value educational content. In a highly pressurised, cost-constrained healthcare environment with increasing demands for value and improved patient outcomes, time-poor …
Brought to you by M3 (EU)
March 24, 2022 | White Papers and Resources |
Over the past four years HRT prescriptions have doubled in the UK, the cause was turbo charged by the action of celebrities and influencers.
Brought to you by Say Communications